Advertisement

Radiology

Home Radiology
Direct secure messaging

Direct Messaging Not Yet Widely Adopted by Physicians

Secure messaging protocol allows for easy communication; meets HIPPA privacy, security rules

April 2018 Briefing – Radiology

Here are what the editors at HealthDay consider to be the most important developments in Radiology for April 2018. This roundup includes the latest...
Women with interstitial cystitis/bladder pain syndrome have white matter abnormalities

White Matter Abnormalities in Female Interstitial Cystitis

Brain abnormalities linked to symptoms of interstitial cystitis/bladder pain syndrome
The widespread shortages of injectable opioids and small-volume parenteral solutions are jeopardizing patient care and placing a strain on hospital operations

ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care

98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
Choosing Wisely, launched in April 2012

‘Choosing Wisely’ Linked to Small Drop in Back Pain Imaging

At 2.5 years after start of the campaign, there was a 4 percent relative reduction in low-value imaging

Screening Nonsmokers May Up Lung Cancer Overdiagnosis, Spurious Survival Rates

Promoting low-dose CT screening among mostly nonsmoking women increased detection of early-stage, but not late-stage, lung cancers

Yoga May Cut Complications With Radiation for Head, Neck Cancer

Findings for yoga delivered in-person or online to patients and their caregivers

Features of Migraine Identified on Functional MRI

Functional connectivity features of amygdala and hippocampus on resting-state fMRI may distinguish migraine

A lesion visible on magnetic resonance imaging identifies a heightened risk for clinically significant prostate cancer in men undergoing first-time prostate biopsy

Combination Biopsy Strategy May Identify More Prostate Cancers

Lesion-targeted plus systematic sampling appears to maximize the accuracy of first-time prostate biopsy
The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb

Head of National Cancer Institute Named Acting FDA Commissioner

Current commissioner, Scott Gottlieb, will be stepping down in April